Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL)
| Assets | $13.02M |
| Expense Ratio | 0.98% |
| PE Ratio | n/a |
| Shares Out | 1.05M |
| Dividend (ttm) | $0.08 |
| Dividend Yield | 0.63% |
| Ex-Dividend Date | Mar 24, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | 88,635 |
| Open | 11.90 |
| Previous Close | 11.63 |
| Day's Range | 11.74 - 12.31 |
| 52-Week Low | 4.67 |
| 52-Week High | 13.67 |
| Beta | 1.79 |
| Holdings | 67 |
| Inception Date | Nov 15, 2017 |
About PILL
Fund Home PageThe Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion.
Top 10 Holdings
43.88% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Finl Sq Trsry Inst 506 | n/a | 18.50% |
| S&P Pharmaceuticals Select Index Swap | n/a | 6.98% |
| Dreyfus Govt Cash Man Ins | n/a | 4.77% |
| Organon & Co. | OGN | 2.68% |
| S&P Pharmaceuticals Select Index Swap | n/a | 2.55% |
| Enliven Therapeutics, Inc. | ELVN | 1.91% |
| Corcept Therapeutics Incorporated | CORT | 1.79% |
| Omeros Corporation | OMER | 1.61% |
| Trevi Therapeutics, Inc. | TRVI | 1.56% |
| Nektar Therapeutics | NKTR | 1.54% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 24, 2026 | $0.01085 | Mar 31, 2026 |
| Dec 23, 2025 | $0.03265 | Dec 31, 2025 |
| Sep 23, 2025 | $0.00985 | Sep 30, 2025 |
| Jun 24, 2025 | $0.02449 | Jul 1, 2025 |
| Mar 25, 2025 | $0.01829 | Apr 1, 2025 |
| Dec 23, 2024 | $0.01305 | Dec 31, 2024 |
Performance
PILL had a total return of 120.36% in the past year, including dividends. Since the fund's inception, the average annual return has been -6.78%.
News
3 Pharmaceutical ETFs That Could Be Due For A Rebound
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...
With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF
With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performance...